GluR7/GRIK3 Antibody (2914A) [Dylight 594]
Novus Biologicals, part of Bio-Techne | Catalog # FAB113281M
Recombinant Monoclonal Antibody.
Conjugate
Catalog #
Key Product Details
Species Reactivity
Human
Applications
Intracellular Staining by Flow Cytometry
Label
DyLight 594 (Excitation = 593 nm, Emission = 618 nm)
Antibody Source
Recombinant Monoclonal Rabbit IgG Clone # 2914A
Concentration
Please see the vial label for concentration. If unlisted please contact technical services.
Product Specifications
Immunogen
Human embryonic kidney cell, HEK293-derived human GluR7/GRIK3
Gly249-Met1
Accession # Q13003
Gly249-Met1
Accession # Q13003
Specificity
Detects human GluR7/GRIK3 in direct ELISA.
Clonality
Monoclonal
Host
Rabbit
Isotype
IgG
Applications for GluR7/GRIK3 Antibody (2914A) [Dylight 594]
Application
Recommended Usage
Intracellular Staining by Flow Cytometry
Optimal dilutions of this antibody should be experimentally determined.
Application Notes
Optimal dilution of this antibody should be experimentally determined.
Formulation, Preparation, and Storage
Purification
Protein A or G purified from hybridoma culture supernatant
Formulation
50mM Sodium Borate
Preservative
0.05% Sodium Azide
Concentration
Please see the vial label for concentration. If unlisted please contact technical services.
Shipping
The product is shipped with polar packs. Upon receipt, store it immediately at the temperature recommended below.
Stability & Storage
Store at 4C in the dark.
Background: GluR7/GRIK3
Long Name
Glutamate Receptor 7
Alternate Names
EAA5, GLR7, GluK3, GRIK3
Additional GluR7/GRIK3 Products
Product Documents for GluR7/GRIK3 Antibody (2914A) [Dylight 594]
Product Specific Notices for GluR7/GRIK3 Antibody (2914A) [Dylight 594]
DyLight (R) is a trademark of Thermo Fisher Scientific Inc. and its subsidiaries.
This product is for research use only and is not approved for use in humans or in clinical diagnosis. Primary Antibodies are guaranteed for 1 year from date of receipt.
Loading...
Loading...
Loading...
Loading...
Loading...
Loading...